We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $4.91M invested in AIM ImmunoTech in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more capital invested

Capital invested by funds: $1.72M → $4.91M (+$3.19M)

7% less funds holding

Funds holding: 14 → 13 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.16M
2
AFM
Anson Funds Management
Texas
+$2.1M
3
PAM
Panagora Asset Management
Massachusetts
+$21.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1K
5
Renaissance Technologies
Renaissance Technologies
New York
+$14K

Top Sellers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
-$10K
2
State Street
State Street
Massachusetts
-$9K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$8K
4
Citadel Advisors
Citadel Advisors
Florida
-$5K
5
Goldman Sachs
Goldman Sachs
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.69M +$2.16M +308 New
AFM
2
Anson Funds Management
Texas
$1.65M +$2.1M +299 New
BIT
3
BlackRock Institutional Trust
California
$604K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$581K +$21.1K +3 +3%
Renaissance Technologies
5
Renaissance Technologies
New York
$199K +$14K +2 +6%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$93K – – –
Northern Trust
7
Northern Trust
Illinois
$21K – – –
OAM
8
Occidental Asset Management
California
$20K – – –
PAM
9
Panagora Asset Management
Massachusetts
$14K +$21.1K +3 New
VKH
10
Virtu KCG Holdings
New York
$13K +$7.02K +1 +100%
BA
11
BlackRock Advisors
Delaware
$7K – – –
BFA
12
BlackRock Fund Advisors
California
$7K – – –
UBS Group
13
UBS Group
Switzerland
$4K – – –
CHC
14
City Holding Co
West Virginia
$1K – – –
GC
15
Guggenheim Capital
Illinois
– -$10K -2 Closed
State Street
16
State Street
Massachusetts
– -$9K -2 Closed
Bank of New York Mellon
17
Bank of New York Mellon
New York
– -$8K -1 Closed
Citadel Advisors
18
Citadel Advisors
Florida
– -$5K -1 Closed
DC
19
Davenport & Co
Virginia
– -$1.15K – –
EWA
20
Exencial Wealth Advisors
Oklahoma
– -$2K – –
Goldman Sachs
21
Goldman Sachs
New York
– -$3K – –
Millennium Management
22
Millennium Management
New York
– -$2K – –
TCM
23
Traynor Capital Management
Pennsylvania
– -$3K – –
TSS
24
Two Sigma Securities
New York
– -$3K – –

AIM Hedge Fund Activity: Q3 2016 in Review

13 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2016, worth a combined $4.91M — up 186% from $1.72M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AIM and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.16M. The largest seller was Guggenheim Capital, exiting entirely with an estimated $10K sold.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q3 2016, down from 14 in Q2 2016.
  • Funds reported $4.91M of AIM ImmunoTech stock for Q3 2016, up 186% quarter-over-quarter.
  • 3 funds opened new AIM ImmunoTech positions in Q3 2016 and 4 closed out, a net change of -1 holder.
  • The largest AIM ImmunoTech buyer in Q3 2016 was Sabby Management, an estimated $2.16M added.
  • The largest AIM ImmunoTech seller in Q3 2016 was Guggenheim Capital, an estimated $10K sold.

Based on aggregated 13F filings for Q3 2016.